Six products.
One network.
Every Peritia product is a pre-vetted slice of our 4,000+ specialist network. Match to the discipline, scope to the problem, staff in under 48 hours.
The protocol depth your program needs without the hiring cycle. Four capability areas — Clinical Development, Biostatistics, Medical Writing, Field Monitoring — matched by therapeutic area and phase.
Explore →Clinical Development
Protocol design, study operations, vendor strategy, program-level leadership.
Biostatistics
Regulatory-grade SAPs, SDTM/ADaM, PK/PD modeling, survival analysis.
Medical Writing
Protocols, CSRs, IBs, safety narratives from ex-industry writers.
Field Monitoring
4,000+ vetted CRAs across 20 countries, risk-based or centralized.
Ex-agency specialists on deck. Regulatory strategy, global submissions, CMC/quality, and agency liaison from people who've been inside the room at FDA, EMA, PMDA, and MHRA.
Explore →Regulatory Strategy
Integrated development & filing strategy, agency interaction plans.
IND / NDA / BLA
Submission leadership, eCTD compilation, response management.
Agency Liaison
Ex-FDA, ex-EMA, ex-PMDA specialists. Type B/C meetings, pre-IND, pre-BLA.
CMC & Quality
Process development, analytical strategy, GMP, tech transfer expertise.
The value story that earns reimbursement. HEOR, HTA strategy across NICE / G-BA / HAS / CADTH, real-world evidence, and value dossier development.
Explore →HEOR
Economic models, budget impact, PRO strategy, meta-analyses.
HTA Strategy
NICE, G-BA, HAS, CADTH, PBAC multi-market planning.
Real-World Evidence
RWD study design, data acquisition, regulatory-grade RWE.
Value Dossiers
AMCP, global value dossiers, payer-ready evidence packages.
Launch planning, medical affairs infrastructure, market access, and brand strategy from people who've been behind the counter on successful launches.
Explore →Launch Planning
Integrated readiness, critical path tracking, functional orchestration.
Medical Affairs
MSL strategy, KOL engagement, publication strategy.
Market Access
Payer strategy, contracting, GPO and IDN navigation.
Brand Strategy
Positioning, messaging architecture, commercial opportunity.
The boardroom-level brain you don't need full-time. Portfolio shaping, investor readiness, pipeline strategy, and commercial due diligence.
Explore →Portfolio Shaping
Asset prioritization, TA focus, trade-off modeling.
Investor Readiness
S-1 support, board materials, diligence response.
Pipeline Strategy
TPP development, go/no-go frameworks, optionality analysis.
Due Diligence
Commercial and scientific diligence for BD and M&A.
When fractional becomes a full-time answer. Executive search for C-suite roles, interim leadership, direct placement, and board advisors.
Explore →Executive Search
CMO, CSO, CDO, Head of Clinical, Head of Regulatory.
Interim Leadership
Functional interim leaders seated in days, not months.
Direct Placement
Permanent placement across life sciences disciplines.
Board Placement
Independent directors, scientific advisors, committees.